Regentatlantic Capital LLC Has $3.40 Million Stake in Danaher Corporation (DHR)

Regentatlantic Capital LLC decreased its stake in Danaher Corporation (NYSE:DHR) by 19.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,652 shares of the conglomerate’s stock after selling 9,474 shares during the period. Regentatlantic Capital LLC’s holdings in Danaher Corporation were worth $3,401,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in DHR. Norway Savings Bank grew its holdings in Danaher Corporation by 0.4% during the second quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock worth $189,000 after purchasing an additional 10 shares during the period. National Asset Management Inc. grew its holdings in Danaher Corporation by 0.4% during the second quarter. National Asset Management Inc. now owns 3,767 shares of the conglomerate’s stock worth $318,000 after purchasing an additional 14 shares during the period. First Financial Corp IN grew its holdings in Danaher Corporation by 0.8% during the second quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock worth $230,000 after purchasing an additional 21 shares during the period. Brighton Jones LLC grew its holdings in Danaher Corporation by 0.4% during the second quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock worth $435,000 after purchasing an additional 21 shares during the period. Finally, Guardian Life Insurance Co. of America grew its holdings in Danaher Corporation by 1.0% during the first quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock worth $202,000 after purchasing an additional 24 shares during the period. Institutional investors own 75.38% of the company’s stock.

DHR has been the subject of a number of research analyst reports. Zacks Investment Research cut Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $83.00 price target on shares of Danaher Corporation in a report on Tuesday, September 26th. Credit Suisse Group lifted their price target on Danaher Corporation from $93.00 to $96.00 and gave the stock an “outperform” rating in a report on Friday, October 20th. BidaskClub upgraded Danaher Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, July 19th. Finally, J P Morgan Chase & Co restated an “overweight” rating and set a $95.00 price objective on shares of Danaher Corporation in a report on Friday, September 8th. One analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. Danaher Corporation currently has an average rating of “Buy” and a consensus price target of $93.31.

WARNING: “Regentatlantic Capital LLC Has $3.40 Million Stake in Danaher Corporation (DHR)” was posted by Markets Daily and is owned by of Markets Daily. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at https://www.themarketsdaily.com/2017/11/14/regentatlantic-capital-llc-has-3-40-million-stake-in-danaher-corporation-dhr.html.

In other Danaher Corporation news, CAO Robert S. Lutz sold 11,189 shares of the business’s stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $91.66, for a total transaction of $1,025,583.74. Following the completion of the transaction, the chief accounting officer now directly owns 18,314 shares in the company, valued at $1,678,661.24. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider William King sold 43,688 shares of the business’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the transaction, the insider now owns 45,748 shares of the company’s stock, valued at $3,790,679.28. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 279,628 shares of company stock valued at $25,304,394. Company insiders own 12.20% of the company’s stock.

Shares of Danaher Corporation (NYSE DHR) opened at $93.33 on Tuesday. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. Danaher Corporation has a 1 year low of $76.27 and a 1 year high of $93.38. The firm has a market cap of $64,162.62, a P/E ratio of 23.71, a PEG ratio of 2.19 and a beta of 1.02.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The company had revenue of $4.53 billion during the quarter, compared to the consensus estimate of $4.47 billion. During the same period in the previous year, the business earned $0.87 earnings per share. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. analysts predict that Danaher Corporation will post 3.99 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were given a dividend of $0.14 per share. The ex-dividend date was Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.60%. Danaher Corporation’s dividend payout ratio is currently 16.52%.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply